A massive real-world study raises new safety questions about widely used IBS treatments, revealing that some commonly prescribed drugs may carry higher long-term risks than previously understood.
WEDNESDAY, April 8, 2026 (HealthDay News) -- For patients with irritable bowel syndrome (IBS), antidepressants and certain antidiarrheal medications are associated with increased mortality risk, ...
Hosted on MSN
Common treatments for irritable bowel syndrome linked to higher risk of death, study warns
Several of the most common treatments for irritable bowel syndrome could raise the risk of death, a study suggests. Irritable bowel syndrome (IBS) is a gastrointestinal disorder that causes a range of ...
Commonly used medications for irritable bowel syndrome (IBS), like antidepressants, are linked to a modest absolute increase in mortality risk. The corresponding study was published in Communications ...
A large U.S. study found some IBS medications are linked to a higher risk of death over time. Antidepressants and certain antidiarrheal drugs showed the strongest associations. Researchers stress the ...
Antidepressants and certain antidiarrheal drugs, such as loperamide and diphenoxylate, were linked to a slightly higher risk for death in adults with irritable bowel syndrome (IBS), according to ...
The researchers found increased mortality risk in association with diphenoxylate and loperamide for IBS with diarrhea. HealthDay News — For patients with irritable bowel syndrome (IBS), ...
Cholestyramine/colestipol, eluxadoline, and rifaximin were not associated with mortality for IBS-D, but an increased mortality risk was seen for diphenoxylate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results